Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig.
about
TularemiaFrom the Outside-In: The Francisella tularensis Envelope and VirulenceTLR-dependent control of Francisella tularensis infection and host inflammatory responsesLive attenuated mutants of Francisella tularensis protect rabbits against aerosol challenge with a virulent type A strain.Role of TLR signaling in Francisella tularensis-LPS-induced, antibody-mediated protection against Francisella tularensis challenge.The fslE homolog, FTL_0439 (fupA/B), mediates siderophore-dependent iron uptake in Francisella tularensis LVS.Rationally designed tularemia vaccines.Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis.Genome sequencing shows that European isolates of Francisella tularensis subspecies tularensis are almost identical to US laboratory strain Schu S4.Modulation of hepatic PPAR expression during Ft LVS LPS-induced protection from Francisella tularensis LVS infection.Gallium disrupts iron uptake by intracellular and extracellular Francisella strains and exhibits therapeutic efficacy in a murine pulmonary infection model.Contributions of Francisella tularensis subsp. novicida chitinases and Sec secretion system to biofilm formation on chitin.EVALUATION OF LIVE TULAREMIA VACCINE PREPARED IN A CHEMICALLY DEFINED MEDIUM.Detoxified endotoxin vaccine (J5dLPS/OMP) protects mice against lethal respiratory challenge with Francisella tularensis SchuS4.Liposome encapsulation of ciprofloxacin improves protection against highly virulent Francisella tularensis strain Schu S4.Mucosal immunotherapy for protection from pneumonic infection with Francisella tularensisDemonstration of opsonizing antibodies to Francisella tularensis by leukocyte chemiluminescenceInfluence of complement on the chemiluminescent response of human leukocytes to immune complex.A galU mutant of Francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemiaPurified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon.IglC and PdpA are important for promoting Francisella invasion and intracellular growth in epithelial cellsA typical preparation of Francisella tularensis O-antigen yields a mixture of three types of saccharides.Enigmatic resistance of sheep (Ovis aries) to infection by virulent Francisella tularensisBiochemical and immunological properties of ribonucleic acid-rich extracts from Francisella tularensisLong lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs.Stimulation of human lymphocytes by a vaccine strain of Francisella tularensisMurine model for study of cell-mediated immunity: protection against death from fully virulent Francisella tularensis infection.Development of functional and molecular correlates of vaccine-induced protection for a model intracellular pathogen, F. tularensis LVS.Visualization of murine intranasal dosing efficiency using luminescent Francisella tularensis: effect of instillation volume and form of anesthesia.A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine.Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemiaHost-pathogen interactions and immune evasion strategies in Francisella tularensis pathogenicityLow dose vaccination with attenuated Francisella tularensis strain SchuS4 mutants protects against tularemia independent of the route of vaccination.Identification of mechanisms for attenuation of the FSC043 mutant of Francisella tularensis SCHU S4.Generation and characterization of an attenuated mutant in a response regulator gene of Francisella tularensis live vaccine strain (LVS).IL-23 p19 knockout mice exhibit minimal defects in responses to primary and secondary infection with Francisella tularensis LVSVirulent Francisella tularensis destabilize host mRNA to rapidly suppress inflammation.Infection-immunity in tularemia: specificity of cellular immunity.Pathogenesis of tularemia in monkeys aerogenically exposed to Francisella tularensis 425Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia.
P2860
Q24535661-EB501085-FCC8-495D-B570-79F4A960EF14Q26771366-2BE9B54A-5655-4413-9147-B737E667A435Q28750216-96817A8D-32C4-4B85-8258-95129AB4EE34Q30409782-A31E2DB3-AD7D-4262-A299-D65EEB7EE7D2Q30424747-39F14767-E8BF-404E-9241-E125F6F639FBQ30432826-8009C617-EED7-4E1C-886A-E93153FB787BQ30436251-DEC6AF69-CB56-416B-87CA-2E81ED290FF9Q30559887-03865EA8-A9E0-439F-8C45-F495447FE5A4Q33281004-F8F9BC7E-44DC-4728-B8F6-54FE49D6714AQ33524893-3A32FF2F-E5B9-4A62-8686-E92523A334F4Q33558904-0EC774B6-80E2-4068-AC07-6147813CBA69Q33585602-13C531F9-9C93-41AF-894F-E8D0C3F5595AQ33696706-9817F421-8F76-4A2E-82F3-737C355D942FQ33759497-D7BCD009-3924-45EC-A3CF-9F33572F193BQ33797873-9778A444-E99E-4C30-A115-AB42F913E175Q33886324-5237A311-9BEB-437E-A7B8-E25D2102DCC6Q33905867-3F71819A-1881-412F-B906-4C42FE5B0D3AQ33905912-05716C2B-3C62-4BE6-AB9D-22C9021C6800Q33983961-870C04A4-D401-4EA9-9541-A769E97AF9A5Q34003871-079DCFF2-4A40-4746-88C2-EF0FB0C2AE5AQ34035513-8AE7A4A8-3453-44C9-B1C9-2DD1BAABF67AQ34076424-D3B68C60-B5EF-4E46-BA91-BC3AD3E3B04AQ34119574-6C43319C-A5F6-4EE7-B823-ED6079ED27E1Q34123590-54B18997-A4F7-4B87-B94D-5451560F1207Q34126301-699E78BB-8954-489F-8C69-EED44B0A02C4Q34129604-A74A09AF-32CD-4223-9444-053E93F0F03DQ34129933-31617A4C-5674-45C6-9F67-A5B2CDBAE3A3Q34139968-F42F9F75-D836-491F-A3DF-99ABC1B0CA4FQ34181668-7AC089F8-D8E1-4783-8481-7199C315B2C4Q34194818-70EBD929-EDF0-4AFD-8088-9A383BC9D2C1Q34200786-B9B25240-05D4-44B6-AC92-8310F6DE9FD1Q34237666-87CB5E91-4B75-4BE9-B780-C81EC1B7C50AQ34291236-8831A519-3FE7-44B4-9C7C-20B5AA68F881Q34298447-0D7431D8-967C-4203-8213-79E8A6917FE3Q34307145-A4EB1206-8322-4727-BB01-FFC8E4ECD035Q34309279-25488F6F-F81D-4805-AE2D-37EAEB77A21AQ34364234-11D27C93-E4B0-47DD-ACED-03BEEB7D19C1Q34469313-479C62C0-23B9-4F14-8DFE-C871EC70889CQ34472504-BF4F7E63-4B6E-4B30-A8E0-1742EF081F49Q34492667-ECA0D59B-6A8A-439C-9DAD-D19FE3503215
P2860
Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig.
description
1961 nî lūn-bûn
@nan
1961年の論文
@ja
1961年学术文章
@wuu
1961年学术文章
@zh
1961年学术文章
@zh-cn
1961年学术文章
@zh-hans
1961年学术文章
@zh-my
1961年学术文章
@zh-sg
1961年學術文章
@yue
1961年學術文章
@zh-hant
name
Prophylactic effectiveness of ...... he white mouse and guinea pig.
@en
Prophylactic effectiveness of ...... he white mouse and guinea pig.
@nl
type
label
Prophylactic effectiveness of ...... he white mouse and guinea pig.
@en
Prophylactic effectiveness of ...... he white mouse and guinea pig.
@nl
prefLabel
Prophylactic effectiveness of ...... he white mouse and guinea pig.
@en
Prophylactic effectiveness of ...... he white mouse and guinea pig.
@nl
P1476
Prophylactic effectiveness of ...... he white mouse and guinea pig.
@en
P2093
EIGELSBACH HT
P304
P407
P577
1961-10-01T00:00:00Z